Chemical,Pharmaceutical sector projects by Shasun Pharmaceuticals Ltd in
Project Information
4747
Shasun Pharmaceuticals Ltd
Shasun Pharmaceuticals And Debiopharma Group, Have Entered Into A Licensing Agreement For The Manufacturing And Commercialization Of Huperzine-A. Shasun Pharmaceuticals Is A Pharma Company From Chennai. And Debiopharma Group Is A Swiss-Based Global Biopharmaceutical Group. According To Agreement, Shasun Pharma Will Be Able To Use The Debiopharm Technology For The Manufacture Of Synthetic Huperzine-A Under GMP Quality Conditions And Commercializes It In Pharmaceutical And Nutraceutical Markets. According To Clinical Studies Huperzine-A Have Shown A Significant Improvement In Memory Deficit And Cognitive Performance In Patients With Alzheimer's Disease. Huperzine-A Is Commercially Available Through Shasun Pharmaceuticals. The Manufacturing Technology Involves A 10-Stage Chemical Synthesis Process Including A Complex Chiral Organometallic Step As A Key Transformation Of The Huperzine-A Structure. The Synthesis Is A Result Of A Joint Collaboration Between Shasun's Research Centers In Chennai And The UK.
Project Value
Refer document
MoU Signed
Not Specified
India
Chemical,Pharmaceutical
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
